Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio.
SurModics (NASDAQ: SRDX) has a PEG ratio of 1.70. SurModics's trailing-twelve-month revenue is $55.68 million.
Trinity Biotech plc (NASDAQ: TRIB) has a PEG ratio of 1.80. Trinity Biotech had $26.81 million in total cash for the latest quarter.
Meridian Bioscience (NASDAQ: VIVO) has a PEG ratio of 2.01. Meridian Bioscience's trailing-twelve-month ROE is 25.63%.
Abaxis (NASDAQ: ABAX) has a PEG ratio 4.44. Abaxis's trailing-twelve-month operating margin is 14.31%.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.